Immunofluorescence analysis of CEOCs and CDCs were carried out according to the established protocol of our lab [26, 27]. Cardiac explants and CDCs were cultured directly on fibronectin coated glass cover slips for immunofluorescence analysis. CEOCS obtained from explants were analyzed for c-kit marker, specific to CPCs and CDCs were analyzed for surface markers, c-kit and CD 105 (specific to CDCs). Cells were fixed with 4% paraformaldehyde for 15 minutes and blocked in blocking buffer (1% BSA in PBS) for 30 minutes at room temperature. Cells were then incubated with primary antibodies, c-kit and CD 105 (1:200 dilution in blocking buffer) overnight at 4°C. Following three PBS washes, cells were incubated with respective fluorescence conjugated secondary antibodies (1:1000) for 1 hour at room temperature. DAPI was used to counterstain nuclei and the cells were visualized using confocal microscope (Carl Zeiss, Zen 2010) with appropriate filters.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.